2 -5 March, 2020
London

Register by Friday, 29th November to save up to £500

Speakers

Alain Beck

Senior Director, Biologics CMC & developability

Pierre Fabre

Alexie Karpov

Senior Investigator I

Novartis

Andrea Gonzalez-Munoz

Research scientist

AstraZeneca

Ashutosh Pathak

VP & Global Head, Medical Affairs

Ascentage Pharma

Balakumar Vijayakrishnan

Group Leader - Conjugation

AZ/Spirogen

Barbara Akla

Senior Scientist

Pierre Fabre

Bart de Goeij

Assistant Director

Genmab

Brian O’Mara

Associate Director - Downstream Process Development

Ambrx

Charles Skarbek

Bioorganic Chemistry Post-doctoral Researcher

Paris Sud

Christopher A. Alabi

Associate Professor

Cornell University

Daejin Abidoye

Vice President, Clinical Development

Seattle Genetics

Dan Custar

Associate Director - Drug Substance CMC

Mersana

Daniel Shweizer

Fellow & Project Leader

Novartis

David Bramhill

Consultant

Bramhill Consulting

Deya Gonzalez

Associate Professor

University of Swansea

Ed Ha

Founding Principal Scientist

AngieX

Eric Lacoste

Head of Bio-Organic Team & Chemistry, Manufacturing, Control & Project Manager

Sanofi

Gavin Bennett

Director & Project Leader

Bicycle Therapeutics

Giorgio Salciarini

Technical Business Development Manager

BSP Pharmaceuticals

Gordon Rigg

Independent Consultant

Guy De Roo

Project Leader, Downstream Processing

Synthon

Hans Georg Lerchen

Research & Development

Bayer

Hillary Schuessler

Scientific Leader

GSK

Iontcho Vlahov

Vice President Discovery Chemistry

Endocyte

Jack Wang

Senior Scientist

Johnson & Johnson

Jacopo Millull

Research Associate Scientist

Philogen

Jagath Reddy Junutula

Senior Vice President - Research & Development

Modmab Therapeutics

Jamie Baker

Reader in Chemical Biology

University College London

James Jim Christie

Scientist

AstraZeneca

Jens Lorhmann

Disease Area Head - Oncology

Novartis

Jeremy Parker

Senior Principal Scientist - New Modalities & Tissue Targeting

AstraZeneca

John Babcook

Senior Vice President of Discovery Research

Zymeworks

John Harlan

Senior Principal Research Scientist

AbbVie

Julian Andreev

Senior Staff Scientist & Research Fellow

Regeneron

Julie Desrivot Guenelle

Project Lead - Pharmacokinetic Pharmacodynamic

Pierre Fabre

Justin Mason Holme

Director

HPAPI Project Services Limited

Justin Sweeley

Senior Technology Manager, Biologics

Novasep

Keiji Furuuchi

Director, Preclinical Development Epochal Precision Anti-Cancer Therapeutics (EPAT), OBG,

Eisai

Letrishka Anthony

Senior Analyst

Beacon Targeted Therapies

Lisa McDermott

Head of Process & Analytical Development

Merck

Luc Desnoyers Alain Beck

Sr. Director of Translational Sciences

CytomX

Mark Frigerio

Director & Vice President - Design, Developability & Chemistry

Abzena

Markus Eser

Laboratory Head

Bayer

Martin Axon

Principal Occupational Hygienist

Safebridge

Naresh Jain

President & Chief Executive Officer

NJ Biopharmaceuticals LLC

Paul Hogg

ADC Therapeutics

Phil Howard

Chief Scientific Officer

Spirogen

Prathap Kumar Mahalingaiah

Senior Scientist III

AbbVie

Rakesh Dixit

CCEO & Founder

BioNavigen

Rich Reynolds

Principal Scientist, Conjugation Process Development

Seattle Genetics

Rick Powers

Independent Consultant

Robert Sussman

Managing Director

Safebridge Consultants

Sam Cazzamali

Research Scientist

Philogen

Sibylle Heidelberger

Senior Specialist - Support

Sciex

Simon Chivers

Independent Consultant

Steffan Woell

Principal Scientist

Merck

Steve Conlan

Professor

University of Swansea

Subhash Chauhan

Professor

University of Tennessee

Thomas Pillow

Senior Scientist

Genentech

Thorsten Sperber

Global Head Medical Affairs

Immunomedics

Trevor Hallam

Chief Scientific Officer

Sutro Bio

Ulf Grawunder

Chief Executive Officer & Founder

NBE Therapeutics

Full Event Guide